Suppr超能文献

脂多糖IVa对脂多糖A刺激犬血单核细胞产生肿瘤坏死因子-α的拮抗活性。

The antagonist activity of lipid IVa on the stimulation by lipid A of TNF-alpha production from canine blood mononuclear cells.

作者信息

Takasawa Kenji, Kano Rui, Maruyama Haruhiko, Hasegawa Atsuhiko, Kamata Hiroshi

机构信息

Department of Pathobiology, Nihon University School of Veterinary Medicine, 1866 Kameino, Fujisawa, Kanagawa 252-0880, Japan.

出版信息

Vet Immunol Immunopathol. 2011 Sep 15;143(1-2):167-9. doi: 10.1016/j.vetimm.2011.06.024. Epub 2011 Jun 15.

Abstract

Lipid A, the active component of lipopolysaccharide (LPS), exists in the outer membrane of Gram-negative bacteria and binds to the Toll-like receptor 4 (TLR4) and MD-2 complex. On the other hand, the synthetic precursor of Escherichia coli lipid A, tetraacylated lipid IVa, is an agonist for TLR4 and MD-2 complex in murine, equine and feline cells but is an antagonist for lipid A in human cells. The aim of the study was to examine the function of canine Toll-like receptor 4 (TLR4) and MD-2 complex on canine blood mononuclear cells (BMC), by analyzing lipid A- or lipid IVa-induction of TNF-α production from these cells in order to understand canine innate immune system. After 5-h culture of canine BMC with lipid A (lipid A culture) or lipid IVa (lipid IVa culture), the TNF-α, as determined by ELISA, had increased in the supernatants of the lipid A cultures in a dose-dependent manner, whereas the TNF-α was undetectable in supernatant of lipid IVa-treated cultures. The TNF-α was statistically significantly different between the lipid A and lipid IVa cultures (100 and 1000 ng/ml). TNF-α production from canine BMC was inhibited, in a lipid IVa-dose-dependent manner, when the BMC were pre-cultured with lipid IVa for 60 min and then cultured with lipid A for 5h, while in control BMC cultures production if TNF-α was unchanged. These results indicate that the TNF-α production stimulated by lipid A was competed out by pre-exposing the BMC to lipid IVa. Thus, lipid A is an agonist for TNF-α production in canine BMC, whereas lipid IVa appears to be an antagonist against this lipid A stimulation of canine BMC.

摘要

脂多糖(LPS)的活性成分脂多糖A存在于革兰氏阴性菌的外膜中,并与Toll样受体4(TLR4)和MD-2复合物结合。另一方面,大肠杆菌脂多糖A的合成前体四酰化脂IVa在鼠、马和猫细胞中是TLR4和MD-2复合物的激动剂,但在人细胞中是脂多糖A的拮抗剂。本研究的目的是通过分析脂多糖A或脂IVa诱导犬血液单核细胞(BMC)产生肿瘤坏死因子-α(TNF-α),来研究犬Toll样受体4(TLR4)和MD-2复合物在犬BMC上的功能,以了解犬的先天免疫系统。用脂多糖A(脂多糖A培养)或脂IVa(脂IVa培养)对犬BMC进行5小时培养后,通过ELISA测定,脂多糖A培养上清液中的TNF-α呈剂量依赖性增加,而脂IVa处理培养上清液中未检测到TNF-α。脂多糖A培养和脂IVa培养之间的TNF-α在统计学上有显著差异(100和1000 ng/ml)。当BMC先用脂IVa预培养60分钟,然后用脂多糖A培养5小时时,犬BMC产生的TNF-α以脂IVa剂量依赖性方式受到抑制,而在对照BMC培养中TNF-α的产生则没有变化。这些结果表明,预先将BMC暴露于脂IVa可竞争掉脂多糖A刺激产生的TNF-α。因此,脂多糖A是犬BMC中TNF-α产生的激动剂,而脂IVa似乎是犬BMC对这种脂多糖A刺激的拮抗剂。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验